Cargando…

New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) is a widespread metabolic disease characterized by chronic hyperglycemia. Human microbiota, which is regarded as a “hidden organ”, plays an important role in the initiation and development of T2DM. In addition, anti-hyperglycemic agents and traditional Chinese medicin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanxia, Wang, Mian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643148/ https://www.ncbi.nlm.nih.gov/pubmed/34876807 http://dx.doi.org/10.2147/DDDT.S334325

Ejemplares similares

Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
por: Li, Jinfan, et al.
Publicado: (2023)

Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies
por: Cao, Thao T. B., et al.
Publicado: (2020)

An overview of traditional Chinese medicine affecting gut microbiota in obesity
por: Li, Donghui, et al.
Publicado: (2023)

Traditional Chinese medicine against COVID-19: Role of the gut microbiota
por: Yang, Zhihua, et al.
Publicado: (2022)

The effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A protocol for systematic review and meta-analysis
por: Zheng, Yujiao, et al.
Publicado: (2020)

Traditional Chinese Medicine Alleviates Ulcerative Colitis via Modulating Gut Microbiota
por: Feng, Wan, et al.
Publicado: (2022)

Effect of Traditional Chinese Medicine on the Gut Microbiota in Heat-Stressed Laying Hens
por: Ye, Chunxin, et al.
Publicado: (2022)

Intestinal Microbiota and Liver Diseases: Insights into Therapeutic Use of Traditional Chinese Medicine
por: Wang, Tingshuai, et al.
Publicado: (2021)

The interactions between traditional Chinese medicine and gut microbiota: Global research status and trends
por: Yang, Shanshan, et al.
Publicado: (2022)

The Role of Gut Microbiota in the Progression of Parkinson’s Disease and the Mechanism of Intervention by Traditional Chinese Medicine
por: Huan, Pengfei, et al.
Publicado: (2022)

Gut microbiota, a hidden protagonist of traditional Chinese medicine for acute ischemic stroke
por: Gao, Lin, et al.
Publicado: (2023)

Prevention and treatment of rheumatoid arthritis through traditional Chinese medicine: role of the gut microbiota
por: Liang, Yujiao, et al.
Publicado: (2023)

New insights into the links between anti-diabetes drugs and gut microbiota
por: Hu, Ruixin, et al.
Publicado: (2020)

Gut brain interaction theory reveals gut microbiota mediated neurogenesis and traditional Chinese medicine research strategies
por: Zhang, Chenxi, et al.
Publicado: (2022)

Synthesis and Evaluation of Novel Pyrroles and Pyrrolopyrimidines as Anti-Hyperglycemic Agents
por: Mohamed, M. S., et al.
Publicado: (2014)

Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents
por: Sekhar, Kuruva Chandra, et al.
Publicado: (2014)

Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis
por: Zhang, Ya-Li, et al.
Publicado: (2019)

Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease
por: Cheng, Tian-Yi, et al.
Publicado: (2021)

Influence of Dietary Components and Traditional Chinese Medicine on Hypertension: A Potential Role for Gut Microbiota
por: Zhang, Guo-Xin, et al.
Publicado: (2021)

Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy
por: Zhu, Li-Ran, et al.
Publicado: (2023)

Gut microbiota: a new angle for traditional herbal medicine research
por: Lin, Longfei, et al.
Publicado: (2019)

A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota
por: Xue, Peng, et al.
Publicado: (2023)

Kombucha tea as an anti-hyperglycemic agent in humans with diabetes – a randomized controlled pilot investigation
por: Mendelson, Chagai, et al.
Publicado: (2023)

Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes
por: Chu, Natural, et al.
Publicado: (2022)

Anti-hyperglycemic effects of three medicinal plants in diabetic pregnancy: modulation of T cell proliferation
por: Yessoufou, Akadiri, et al.
Publicado: (2013)

The Enhanced Pharmacological Effects of Modified Traditional Chinese Medicine in Attenuation of Atherosclerosis Is Driven by Modulation of Gut Microbiota
por: Ji, Wenyan, et al.
Publicado: (2020)

Interaction of gut microbiota with the tumor microenvironment: A new strategy for antitumor treatment and traditional Chinese medicine in colorectal cancer
por: Li, Tingting, et al.
Publicado: (2023)

Ferroptosis and Traditional Chinese Medicine for Type 2 Diabetes Mellitus
por: Xie, Dandan, et al.
Publicado: (2023)

Application of traditional Chinese medicine as skin depigmentation agents
por: Liu, Tina, et al.
Publicado: (2022)

An Invertebrate Hyperglycemic Model for the Identification of Anti-Diabetic Drugs
por: Matsumoto, Yasuhiko, et al.
Publicado: (2011)

Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine – a case study of diabetes and nonalcoholic fatty liver disease
por: Bao, Yang, et al.
Publicado: (2022)

Characteristics and differences of gut microbiota in patients with different Traditional Chinese Medicine Syndromes of Colorectal Cancer and normal population
por: Wang, Peipei, et al.
Publicado: (2020)

Arsenic Bioaccessibility of Realgar Influenced by the Other Traditional Chinese Medicines in Niuhuang Jiedu Tablet and the Roles of Gut Microbiota
por: Xu, Wenfeng, et al.
Publicado: (2019)

The impact of Traditional Chinese Medicine on mouse gut microbiota abundances and interactions based on Granger causality and pathway analysis
por: Zhang, Yi, et al.
Publicado: (2022)

The effects of traditional Chinese medicine and dietary compounds on digestive cancer immunotherapy and gut microbiota modulation: A review
por: Feng, Xiaoli, et al.
Publicado: (2023)

Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus
por: Zhang, Boxun, et al.
Publicado: (2019)

Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function
por: Wang, Yi-Feng, et al.
Publicado: (2022)

Insights into the Action Mechanisms of Traditional Chinese Medicine in Osteoarthritis
por: Li, Linfu, et al.
Publicado: (2017)

Exosomes: A novel insight into traditional Chinese medicine
por: Mo, Chao, et al.
Publicado: (2022)

Traditional Chinese Medicines in Treatment of Patients with Type 2 Diabetes Mellitus
por: Xie, Weidong, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_56fsuik8qlm6bfeuuld9dvcqme